REPLY
1.9.2021 10:02:12 CEST | Business Wire | Press release
Reply’s latest research “Industrial IoT: A Reality Check ” explores two key areas that are driving the growth of IoT within the industrial market: smart factory and smart transport & logistics. By connecting machinery and tools, the Industrial IoT (IIoT) enables manufacturing companies to improve the visibility of their production in real time. The huge amount of data generated by Industrial IoT devices constitutes the fuel for optimising production, improving the delivery quality, introducing predictive maintenance, automating the supply chain and much more.
“Without the Industrial IoT, Industry 4.0 cannot exist. Data are the fuel for all “smart” use cases in the industrial world; Industrial IoT is the crucial element that guarantees the infrastructure to collect data, to send them to the cloud and to manage the feedback post-analysis, all as part of a virtuous circle of benefits to business”, explains Filippo Rizzante, Reply CTO.
Market growth
The research , carried out thanks to the data collected with the use of the proprietary Trend Sonar platform and the support provided by the Teknowlogy Group, also examines the main markets for smart factories and smart transport & logistics, grouped into two clusters: “Europe-5” (Germany, Italy, France, Belgium and the Netherlands) and “Big-5” (the USA, China, India, Brazil and the UK).
Despite the though economic climate of 2020, both clusters saw a small growth in investments in smart factories, as well as in the smart transport & logistics area, while further and much more significant growth is expected by 2025. Overall, the smart factory market of the “Big-5” cluster , led by the US, is expected to exceed €86 billion by 2025, with strong investments in platforms, predictive solutions and remote monitoring. The smart transport & logistics market is set to exceed €15 billion. In the “Europe-5” cluster , on the other hand, the smart factory market is expected to nearly triple in all countries, reaching a total of over €23 billion in the five countries in question, with Germany in the lead. Platforms are set to experience exponential growth and businesses will invest to manage quality better and to reduce costs. Germany will also remain the leader in the smart transport & logistics area, but the other countries in the cluster will still see significant growth. This Cluster is expected to reach a total value of €3.6 billion in 2025.
The drive of 5G and edge computing
The adoption of low-cost sensors and 5G networks, driven by large investments by Telcos, will further improve the diffusion of Industrial IoT. For example, improved communication between autonomous vehicles/robots, artificial intelligence and machinery, combined with increased computing power and very low latency, is expected to improve not only the efficiency of plants, but also their safety. Moreover, the ability to create high-density private networks will enable a wider deployment of the Industrial IoT, as well as the connection of a significant number of sensors, machinery, vehicles and robots, complemented by a greater use of augmented and virtual reality to support “connected workers”.
Cybersecurity is a crucial factor
The constant growth of connected devices and their heterogeneity requires bold security management of the setup and maintenance policy of both devices and networks. Based on its experience, Reply believes that organisations need to adopt micro-segmented environments (on-premises and/or cloud-based), which are stable and ready to react to both traditional and new dangerous technologies and techniques, thus reducing the probability that new types of attacks will be successful. The analysis of IoT architecture, of industrial components and of entire infrastructures will help companies to eliminate existing gaps, vulnerabilities and threats in advance. But this is much more than merely a technological issue: training programmes aimed at employees, together with the study and continuous testing of all devices used will also be crucial.
From factories to consumers
If, in recent years, Industrial Internet of Things technologies have been adopted and used, above all, to improve the efficiency of factories and logistics centres, during the pandemic, new investments have been directed primarily towards improving worker safety. The long-term trend, however, is expected to directly involve final consumers. The success of so-called “connected products” is, in fact, accelerating investments towards solutions in which the collection and processing of usage data does not only involve production machinery, but also the use of finished products. The redesign of design, production and distribution processes of IoT-connected products is enabling the creation of value-added services and facilitating the ability to remotely update and maintain household appliances, cars, robots, electronics and entertainment devices.
For more information on the “Industrial IoT: A Reality Check ” research. This new research is part of the Reply Market Research series, which includes the “From Cloud to Edge” , “New Interfaces, Zero Interfaces” and “Beyond Digital Marketing ” papers.
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media and the Internet of Things. Reply’s services include: Consulting, Systems Integration and Digital Services. www.reply.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005080/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom